IQV

IQVIA Holdings Inc. (IQV)

NYSE: IQVUSD
163.85 USD
-4.43 (-2.64%)
AT CLOSE (11:59 AM EDT)
163.16
-0.70 (-0.42%)
POST MARKET (AS OF 08:15 PM EDT)
🔴Market: CLOSED
Open?$167.58
High?$168.54
Low?$162.36
Prev. Close?$163.85
Volume?1.5M
Avg. Volume?2.2M
VWAP?$164.88
Rel. Volume?0.69x
Bid / Ask
Bid?$157.80 × 100
Ask?$189.96 × 100
Spread?$32.16
Midpoint?$173.88
Valuation & Ratios
Market Cap?27.5B
Shares Out?169.7M
Float?160.5M
Float %?94.6%
P/E Ratio?20.22
P/B Ratio?4.23
EPS?$8.10
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.75Weak
Quick Ratio?0.75Weak
Cash Ratio?0.24Low
Debt/Equity?2.42High
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
20.2FAIR
P/B?
4.23FAIR
P/S?
1.69CHEAP
P/FCF?
13.4CHEAP
EV/EBITDA?
12.0FAIR
EV/Sales?
2.53CHEAP
Returns & Efficiency
ROE?
20.9%STRONG
ROA?
4.5%FAIR
Cash Flow & Enterprise
FCF?$2.1B
Enterprise Value?$41.2B
Related Companies
Loading...
News
Profile
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Employees
93.0K
Market Cap
27.5B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2013-05-09
Address
2400 ELLIS ROAD
DURHAM, NC 27703
Phone: 919-998-2000